MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial

R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian (Piscataway, NJ, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 844

Keywords: Anxiety, Depression, Parkinsonism

Category: Parkinson's Disease: Psychiatric Manifestations

Objective: For the nearly 100,000 veterans with Parkinson’s disease (PD) receiving Veterans Affairs (VA) health care, depression is prevalent, yet often undiagnosed or undertreated. This treatment gap undermines PD management and accelerates functional decline. Effective depression treatment can be restorative, yet there is currently no evidence-based standard of care in the VA for veterans with depression and PD (dPD). This study compared the effectiveness of video-to-home cognitive-behavioral therapy (CBT) to VA depression treatment as usual (TAU) for veterans with dPD.

Background: In two prior RCTs, brief, PD-informed CBT for dPD significantly outperformed usual care, whether CBT was provided in person or remotely. Veterans with Parkinson’s (VWP) represent a high-need (medically/psychiatrically complex) cohort facing geographic and disability-related obstacles to specialized, evidence-based care. VA’s telemedicine capabilities can bypass these barriers and extend PD-informed mental health treatment to these underserved veterans.

Method: Ninety VWP were randomized to video-to-home CBT+TAU or TAU only. CBT was individualized to veterans’ unique needs and provided weekly for 3 months, then monthly through 6-month follow-up. Care-partners received ancillary coaching to support VWPs’ CBT coping skills.

Results: Treatment feasibility, satisfaction, and adherence rates were high. Over the course of the trial, veterans receiving CBT achieved significant, durable reductions in depression, compared to TAU, on clinician-administered (Hamilton Rating Scale for Depression) and self-report (Beck Depression Inventory) measures (p<.001). Significantly more veterans in CBT qualified as “treatment responders” with depression “very much improved ” or “much improved” from baseline; Clinical Global Impression Improvement Scale; p<.001). Gains in anxiety, physical functioning, and quality of life also favored CBT (p<.05).

Conclusion: Brief, PD-informed CBT for depression, delivered via video-to-home, could significantly enhance VA’s standard PD care, improving global PD treatment outcomes. It is notable that this telemedicine intervention was both feasible and effective for veterans with PD with significant medical and psychiatric burden.

To cite this abstract in AMA style:

R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian. Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/video-to-home-cognitive-behavioral-therapy-for-veterans-with-depression-and-parkinsons-disease-a-randomized-controlled-trial/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/video-to-home-cognitive-behavioral-therapy-for-veterans-with-depression-and-parkinsons-disease-a-randomized-controlled-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley